Retinal microvascular dysfunction in patients with coronary artery disease with and without heart failure: a continuum?

Atrial FibrillationHeart, Artery and Coronary DiseasesHeart Failure

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF

Eur Heart J.

Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan RS, Beussink-Nelson L, Fermer ML, Broberg MA, Gan LM, Lund LH

doi: 10.1093/eurheartj/ehy531.

Atrial FibrillationHeart, Artery and Coronary DiseasesHeart Failure

Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction

JAMA Cardiol.

Chatterjee NA, Moorthy MV, Pester J

Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesHeart Failure

Retinal microvascular dysfunction in heart failure

Eur Heart J.

Nägele MP, Barthelmes J, Ludovici V, Cantatore S, von Eckardstein A, Enseleit F, Lüscher TF, Ruschitzka F, Sudano I, Flammer AJ

doi: 10.1093/

Cardiovascular Risk and Diseases

Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation-A Multi-Center Observational Cohort Study

J Am Heart Assoc.

Tabata N, Yamamoto E, Hokimoto S, Yamashita T, Sueta D, Takashio S, Arima Y, Izumiya Y, Kojima S, Kaikita K, Matsui K, Fujimoto K, Sakamoto K, Shimomura H, Tsunoda R, Hirose T, Nakamura N, Sakaino N, Nakamura S, Yamamoto N, Matsumura T, Kajiwara I, Koide S, Sakamoto T, Nakao K, Oshima S, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators

doi: 10.1161/JAHA.117.006355.

Cardiac Arrest or DeathHeart FailureTherapy and Intervention

Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.

Circulation.

Rao MP, Al-Khatib SM, Pokorney S, She L, Romanov A, Nicolau JC, Lee KL, Carson PE, Selzman CH, Stepinska J, Cleland JG, Tungsubutra W, Desvigne-Nickens PM, Sueta C, Siepe M, Lang IM, Feldman AM, Yii M, Rouleau JL, Velazquez EJ

doi: 10.1161/CIRCULATIONAHA.

Heart, Artery and Coronary DiseasesHeart Failure

The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)

J Am Coll Cardiol.

Joseph P, Swedberg K, Leong DP, Yusuf S

doi: 10.1016/j.jacc.2019.04.067.

Heart, Artery and Coronary DiseasesTherapy and Intervention

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data

Lancet.

Head SJ, Milojevic M, Daemen J, Ahn JM, Boersma E, Christiansen EH, Domanski MJ, Farkouh ME, Flather M, Fuster V, Hlatky MA, Holm NR, Hueb WA, Kamalesh M, Kim YH, Mäkikallio T, Mohr FW, Papageorgiou G, Park SJ, Rodriguez AE, Sabik JF 3rd, Stables RH, Stone GW, Serruys PW, Kappetein AP

doi: 10.1016/S0140-6736

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease: Insights From the SYNTAX III REVOLUTION Trial

Circ Cardiovasc Interv.

Andreini D, Modolo R, Katagiri Y, Mushtaq S, Sonck J, Collet C, De Martini S, Roberto M, Tanaka K, Miyazaki Y, Czapla J, Schoors D, Plass A, Maisano F, Kaufmann P, Orry X, Metzdorf PA, Folliguet T, Färber G, Diamantis I, Schönweiß M, Bonalumi G, Guglielmo M, Ferrari C, Olivares P, Cavallotti L, Leal I, Lindeboom W, Onuma Y, Serruys PW, Bartorelli AL, SYNTAX III REVOLUTION Investigators.

doi: 10.1161/CIRCINTERVENTIONS.118.007607.

RECOMMENDED

Heart Failure

Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease

N Engl J Med.

Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators

doi: 10.1056/NEJMoa1808848.

Related content